Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes

British Journal of Pharmacology

Volumn 129, Issue 2, 2000, Pages 323-330

  Coker, Susan J ^a   Batey, Andrew J ^a   Lightbown, Ian D ^a   Díaz, Mary E ^a   Eisner, David A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Action potential duration; AV block; Cardiac contractility; ECG intervals; Effective refractory period; Hypotension; Mefloquine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MEFLOQUINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; CALCIUM CURRENT; CALCIUM TRANSPORT; CARDIOTOXICITY; CONTROLLED STUDY; DEPRESSOR RESPONSE; ELECTROCARDIOGRAM; GUINEA PIG; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; HYPOTENSION; IN VIVO STUDY; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0033969518     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703060     Document Type: Article

References (27)

1. Batey, A.J., Lightbown, I.D., Lambert, J.P., Edwards, G. & Coker, S.J. (1997). Comparison of the acute cardiotoxicity of the antimalarial drug halofantrine in vitro and in vivo in anaesthetized guinea pigs. Br. J. Pharmacol., 122, 563-569.
2. Ben-David, J. & Zipes, D.P. (1993). Torsade de pointes and proarrhythmia. Lancet, 341, 1578-1582.
3. Coker, S.J. & Batey, A.J. (1996). Mefloquine, an antimalarial drug: effects on the contractile function and the effective refractory period of guinea pig isolated cardiac muscle preparations. Br. J. Pharmacol., 119, 95P.
4. Coker, S.J., Lightbown, I.D., Hughes, D.A., Lambert, J.P. & Edwards, G. (1998). Mefloquine potentiates halofantrine-induced QTc prolongation by altering the distribution of halofantrine. Br. J. Pharmacol., 123, 88P.
5. Davies, T.M.E., Dembo, L.G., Kaye-Eddie, S.A., Hewitt, B.J., Hislop, R.G. & Batty, K.T. (1996). Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double blind, placebo-controlled trial. Br. J. Clin. Pharmacol., 42, 415-421.
6. Diaz, S.J., Eisner, D.A. & Coker, S.J. (1998). Shortening of action potential duration by the antimalarial agent mefloquine in isolated guinea pig ventricular myocytes. J. Physiol., 509P, 149P-150P.
7. Eisner, D.A., Nichols, C.G., O'Neill, S.C., Smith, G.L. & Valdeolmillos, M. (1989). The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J. Physiol., 411, 393-418.
8. Essien, E.E. & Ette, E.I. (1986). Effects of chloroquine and didesethylchloroquine on rabbit myocardium and mitochondria. J. Pharm. Pharmacol., 38, 543-546.
9. 2+ uptake by crude microsomcs of rabbit skeletal muscle. Arch. Int. Pharmacodyn., 329, 255-271.
10. Horn, R. & Marty, A. (1988). Muscarinic activation of ionic currents measured by a new whole-cell recording method. J. Gen. Physiol., 92, 145-159.
11. Hughes, D.A. & Coker, S.J. (1994). Cardiovascular response to acute chloroquine poisoning. J. Mol. Cell. Cardiol., 26, CCLIX.
12. Ikhinmwin, M.K., Sofola, O.A. & Elebute, O. (1981). The effects of calcium ions on the depression of cardiac contractility by chloroquine and quinine. Eur. J. Pharmacol., 69, 507-510.
13. Jaeger, A., Sauder, P., Kopferschmitt, J & Flesch, F. (1987). Clinical features and management of poisoning due to antimalarial drugs. Medical Toxicology, 2, 242-273.
14. Karbwang, J. & White, N.J. (1990). Clinical pharmacokinetics of mefloquine. Clin. Pharmacokinet., 19, 264 -279.
15. Laothavorn, P., Karbwang, J., Na Bangchang, K., Bunnag, D. & Harinasuta, T. (1992). Effect of mefloquine on electrocardiographic changes in uncomplicated falciparum malaria patients. Southeast Asean J. Trop. Med. Public Health, 23, 51-54.
16. 2+ uptake and release by dog brain microsomes. Arch. int. Pharmacodyn., 331, 221-231.
17. Marshall, R.J. & Ojewole, J.A.O. (1978). Comparative effects of some antimalarial drugs on isolated cardiac muscle of the guinea pig. Toxicol. Appl. Pharmacol., 46, 759-768.
18. Molnar, J., Wiess, J.S. & Rosenthal, J.E. (1995). The missing second: what is the correct unit for the Bazett corrected QT interval? Am. J. Cardiol., 75, 537-538.
19. Napolitano, C., Priori, S.G. & Schwartz, P.J. (1994). Torsades de pointes. Mechanisms and management. Drugs. 41, 51-65.
20. Nori, V.S. & Barry, S.R. (1997). Toxic effects of antimalarial drugs in Paramecium: role of calcium channels. J. Comp. Physiol. A, 180, 473-480.
21. Nosten, F., Ter Kuile, F.O., LUXEMBERGER, C., Woodrow, C., Kyle, D.E., Chongsuphajaisiddhi, T. & White, N.J. (1993). Cardiac effects of antimalarial treatment with halofantrine. Lancet, 341, 1054-1056.
22. i. J. Physiol., 425, 55-70.
23. Richter, J., Burbach, G., Hellgren, U., Dengler, A. & Bienzle, U. (1997). Aberrant atrioventricular conduction triggered by antimalarial prophylaxis with mefloquine. Lancet, 349, 101-102.
24. Riou, B., Barriot, P., Rimailho, A. & Baud, F.J. (1988). Treatment of severe chloroquine poisoning. New Engl. J. Med., 318, 1-6.
25. Scholtysik, G. (1980). Retardation of aconitine-induced ECG-alterations in rats as an indication of membrane-stabilizing drug effects. In: The rat electrocardiogram in pharmacology and toxicology, eds: Budden R. Detweiler D.K. & Zbinden G., Oxford, Pergamon Press Ltd. pp 257-264.
26. Tona, L., Ng, Y.-C., Akera, T. & Brody, T.M. (1990). Depressant effects of chloroquine on the isolated guinea-pig heart. Eur. J. Pharmacol., 178, 293-301.
27. Winstanley, P. (1996). Mefloquine: the benefits outweigh the risks. Br. J. Clin. Pharmacol., 42, 411-413.